Results · Apr-Jun 2026 · filed 13 Aug 2026
Alpa Laboratories Q1 FY27 results
Sales grew 25% to ₹23.9 crore from ₹19.1 crore in Apr-Jun 2025.
Operating profit fell 1033% to −₹4 crore, an operating margin of −16.5% (down 18.8 points from a year ago).
Net profit fell 92% to ₹0.98 crore from ₹11.8 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −24%, net profit −29%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 23.9 | 19.1 | +25% |
| Operating profit (EBITDA) | -4.0 | 0.4 | −1033% |
| Operating margin | −16.5% | 2.2% | −18.8 pts |
| Net profit | 1.0 | 11.8 | −92% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 13 Aug 2026Results For The Quarter Ended June 2026
- 11 Aug 2026CLARIFICATION ON BOARD MEETING
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.